ResearcherKyung Hee UniversityActive in the last 2 years
Kwang Seok Ahn
Matched on ORCID iD 0000-0002-2882-0612; OpenAlex author ID A5037236595.
Their work
- Papers
- 5 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 4
2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper
Papers 5
- Pyrazolo-quinolinone suppresses epithelial-mesenchymal transition by targeting the CXCR4/NF-κB axis in human pancreatic cancer cells. Last author DOI 10.1016/j.prp.2026.156547↗
- Cannabidiol Suppresses EMT in Pancreatic Cancer via Inhibition of MALAT1 lncRNA and PI3K/Akt/mTOR Signaling Pathway. Last author DOI 10.1002/iub.70042↗
- Triazolyl-indolo-quinoxaline triggers differential cell death pathways in pancreatic cancer via ROS/p38 axis. Last author DOI 10.1016/j.cbi.2025.111668↗
- A new isoxazolyl-urea derivative induces apoptosis, paraptosis, and ferroptosis by modulating MAPKs in pancreatic cancer cells. Last author DOI 10.1016/j.biochi.2024.08.001↗
- LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway. Last author DOI 10.1002/jcp.30229↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Young Yun Jung · 4 shared papers, 2021–2026
- Paper Cannabidiol Suppresses EMT in Pancreatic Cancer via Inhibition of MALAT1 lncRNA and PI3K/Akt/mTOR Signaling Pathway. DOI 10.1002/iub.70042↗
- Paper Pyrazolo-quinolinone suppresses epithelial-mesenchymal transition by targeting the CXCR4/NF-κB axis in human pancreatic… DOI 10.1016/j.prp.2026.156547↗
- Paper A new isoxazolyl-urea derivative induces apoptosis, paraptosis, and ferroptosis by modulating MAPKs in pancreatic cance… DOI 10.1016/j.biochi.2024.08.001↗
- Bada Yoon · 2 shared papers, 2025–2026
- Paper Pyrazolo-quinolinone suppresses epithelial-mesenchymal transition by targeting the CXCR4/NF-κB axis in human pancreatic… DOI 10.1016/j.prp.2026.156547↗
- Paper Triazolyl-indolo-quinoxaline triggers differential cell death pathways in pancreatic cancer via ROS/p38 axis. DOI 10.1016/j.cbi.2025.111668↗
- Na Young Kim · 1 shared paper, 2025
- Darshini Gowada · 1 shared paper, 2026
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.